SCHEMBL11293448

SCHEMBL11293448

O=C(Cc1nc(=O)[nH]cc1Cl)c1cccs1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.45
LMNA P02545 4/20 0.44
POLB P06746 3/20 0.44
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CTNNB1 P35222 3/20 0.40
WNT3A P56704 2/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HPGD P15428 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ERCC5 P28715 1/20 0.39
FEN1 P39748 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11292813 0.87 ALDH1A1 (0.49) GSK3BLMNAPOLBALDH1A1NPC1
SCHEMBL11290653 0.84 ALDH1A1 (0.44) GSK3BLMNAPOLBALDH1A1NPC1
SCHEMBL11287141 0.84 NPC1 (0.44) GSK3BLMNAPOLBALDH1A1NPC1
SCHEMBL11292164 0.78 POLB (0.40) GSK3BLMNAPOLBALDH1A1NPC1
SCHEMBL11269374 0.78 RAB9A (0.48) GSK3BLMNAPOLBALDH1A1NPC1
SCHEMBL11291348 0.76 CES2 (0.37) POLBALDH1A1NPC1RAB9AKMT2A
SCHEMBL11159833 0.75 PARP1 (0.43) LMNAPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL11269287 0.74 NPC1 (0.45) POLBALDH1A1NPC1RAB9AKMT2A
SCHEMBL11271605 0.73 RAB9A (0.40) LMNAPOLBALDH1A1NPC1RAB9A
SCHEMBL11285028 0.72 PKM (0.41) ALDH1A1NPC1RAB9ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0044705-A1 Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor GLAXO GROUP LIMITED (GB) 1982-01-27 EP disclosed